Role of Coenzyme Q in ADHD in Children
NCT04216186 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2020-01-02
Summary
Role of Coenzyme Q in ADHD in Children
Conditions
- ADHD
Interventions
- DRUG
-
Atomoxetine
Atomoxetine once daily
- DRUG
-
Coenzyme Q
Coenzyme Q once daily
Sponsors & Collaborators
-
Sherief Abd-Elsalam
lead OTHER
Principal Investigators
-
Fatma G. Abdelkader, Msc · Pediatrics department - Kafr Elsheikh University
-
Osama A Elagamy, Prof. · Pediatrics department - Kafr Elsheikh University
-
Abeer Salamah, Lecturer · Pediatrics department - Kafr Elsheikh University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2030-12-01
- Completion
- 2030-12-01
Countries
- Egypt
Study Locations
More Related Trials
-
Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD
NCT00214981 ·Status: COMPLETED ·Phase: PHASE3
-
System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2
NCT03523663 ·Status: TERMINATED
-
The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder
NCT00773916 ·Status: COMPLETED ·Phase: PHASE4
-
Methylphenidate in Healthy Young Adults
NCT00815841 ·Status: UNKNOWN ·Phase: PHASE4
-
Stimulant Effects on Brain Activity
NCT02453698 ·Status: COMPLETED ·Phase: PHASE1
-
The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study
NCT03936491 ·Status: COMPLETED ·Phase: NA
-
Cost-effectiveness of the Treatment of Attention Deficit/Hyperactivity Disorder With Methylphenidate Immediate-release in Brazil
NCT01705613 ·Status: COMPLETED
-
Towards an Understanding of the Mechanism of Action of Methylphenidate in ADHD
NCT05600881 ·Status: NOT_YET_RECRUITING
-
Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children
NCT03436017 ·Status: COMPLETED
-
Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
NCT00315276 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
NCT02780102 ·Status: COMPLETED ·Phase: NA
-
Effects of Ritalin on Postural Stability of Hyper Active Children
NCT00485797 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children
NCT04569357 ·Status: COMPLETED ·Phase: PHASE3
-
Black Seed Oil in ADHD
NCT06542887 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
NCT01816074 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
NCT00228540 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
NCT02578030 ·Status: COMPLETED ·Phase: PHASE1
-
Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children
NCT01065259 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest
NCT02473185 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.
NCT02163915 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
NCT03325881 ·Status: COMPLETED ·Phase: PHASE3
-
QbTest Utility for Optimising Treatment in ADHD (QUOTA)
NCT03368573 ·Status: COMPLETED ·Phase: NA
-
Enhancement of Methylphenidate Treatment by Psychosocial Intervention and Support
NCT01660425 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder
NCT00467428 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD
NCT06359899 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3